Antidepressants and alcohol use disorder: A multicenter study on the mediating role of depression symptom changes

被引:1
|
作者
Jaeger, Joshua [1 ,2 ]
Osterburg, Lara [3 ]
Stein, Maria [1 ,3 ]
Germann, Miranda [3 ]
Lustenberger, Sara A. [3 ]
Wopfner, Alexander [4 ]
Denier, Niklaus [3 ]
Bracht, Tobias [3 ]
Moggi, Franz [3 ]
Soravia, Leila M. [3 ,4 ]
机构
[1] Univ Bern, Inst Psychol, Dept Clin Psychol & Psychotherapy, Bern, Switzerland
[2] Vrije Univ Amsterdam, Dept Comp Sci, Quantitat Data Analyt Grp, Amsterdam, Netherlands
[3] Univ Bern, Univ Hosp Psychiat, Translat Res Ctr, Bern, Switzerland
[4] Clin Suedhang, Kirchlindach, Switzerland
来源
ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH | 2024年 / 48卷 / 08期
基金
瑞士国家科学基金会;
关键词
alcohol use disorder; antidepressants; depressive symptoms; mediation analysis; percent days of abstinence; SUBSTANCE USE DISORDERS; COMORBID ALCOHOL; DEPENDENT PATIENTS; MEDICATIONS; EFFICACY; ADOLESCENTS; TRIALS;
D O I
10.1111/acer.15386
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
BackgroundAlcohol use disorder (AUD) and depression are highly prevalent and tied to significant psychological, physiological, social and economic consequences. Their co-occurrence presents a complex clinical challenge, as the impact of antidepressant medication on AUD outcomes remains equivocal. In this multicenter, longitudinal study we investigated the relationship between antidepressant medication and changes in depression symptoms and alcohol use in AUD patients.MethodsWe analyzed data from 153 detoxified AUD patients who attended a 12-week residential treatment program between 2015 and 2019. Within a mediation analysis, adopting a bootstrapping approach and a quasi-Bayesian framework, we estimated the total, direct, and mediated effects of antidepressants on the percentage of days abstinent to assess the role of changes in depression symptoms as a mediating factor.ResultsThe mediation analysis revealed a dual impact pathway model with a negative direct effect of antidepressants on abstinence (p = 0.004) and a positive indirect effect, mediated through the reduction of depression symptoms (p = 0.002).ConclusionsThe findings of the mediation analysis show that patients treated with antidepressants and whose depression symptoms do not improve over time show more relapses, while patients treated with antidepressants who achieve a reduction in depression symptoms show fewer relapses over time. Thus, to optimize treatment outcome, depression symptoms should be vigilantly monitored when antidepressants are prescribed during AUD treatment. Alcohol use disorder (AUD) and depression symptoms often co-occur and present a complex clinical challenge, as the impact of antidepressant medication on AUD outcomes remains ambiguous. In a multicenter, longitudinal study we investigated the relationship between antidepressant medication, changes in depression symptoms, and alcohol use. The mediation analysis revealed a negative direct effect of antidepressants on abstinence and a positive indirect effect, mediated through the alleviation of depression symptoms, highlighting the importance of monitoring of depression symptoms during AUD treatment.image
引用
收藏
页码:1577 / 1585
页数:9
相关论文
共 50 条
  • [41] Symptom Network Structure as a Predictor of Comorbid Alcohol Use Disorder among Individuals with an Internalizing Disorder
    Anker, Justin
    Thuras, Paul
    Kushner, Matt
    BIOLOGICAL PSYCHIATRY, 2017, 81 (10) : S364 - S364
  • [42] Endorsement of specific alcohol use disorder criterion items changes with age in individuals with persistent alcohol use disorders in 2 generations of the San Diego Prospective Study
    Schuckit, Marc A.
    Smith, Tom L.
    ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH, 2021, 45 (10): : 2059 - 2068
  • [43] Ibudilast for alcohol use disorder: study protocol for a phase II randomized clinical trial
    Burnette, Elizabeth M.
    Baskerville, Wave-Ananda
    Grodin, Erica N.
    Ray, Lara A.
    TRIALS, 2020, 21 (01)
  • [44] Prescription for antidepressant in reducing future alcohol-related readmission in patients suffering from depression and alcohol use disorder: a retrospective medical record review
    Chan, Patrick
    Yomen, Katie
    Turcios, Jennifer
    Richman, Mark
    SUBSTANCE ABUSE TREATMENT PREVENTION AND POLICY, 2015, 10
  • [45] Double-blind placebo-controlled trial of fluoxetine in adolescents with comorbid major depression and an alcohol use disorder
    Cornelius, Jack R.
    Bukstein, Oscar G.
    Wood, D. Scott
    Kirisci, Levent
    Douaihy, Antoine
    Clark, Duncan B.
    ADDICTIVE BEHAVIORS, 2009, 34 (10) : 905 - 909
  • [46] Fluoxetine in adolescents with comorbid major depression and an alcohol use disorder: a 3-year follow-up study
    Cornelius, JR
    Clark, DB
    Bukstein, OG
    Kelly, TM
    Salloum, IM
    ADDICTIVE BEHAVIORS, 2005, 30 (04) : 807 - 814
  • [47] DSM-5 in patients seeking their first treatment for alcohol use disorder. Sex differences in the multicenter CohRTA study
    Sanvisens, Arantza
    Zuluaga, Paola
    Rubio, Gabriel
    Short, Antoni
    Gual, Antoni
    Javier Alvarez, Francisco
    Torrens, Marta
    Rodriguez de Fonseca, Fernando
    Muga, Roberto
    ADICCIONES, 2020, 32 (02) : 136 - 144
  • [48] Association between body roundness index and sleep disorder: the mediating role of depression
    Gong, Hongyang
    Zhao, Yunkai
    BMC PSYCHIATRY, 2025, 25 (01)
  • [49] The Mediating Role of the Addictions Neuroclinical Assessment Domain Factors in the Relationship Between Childhood Trauma and Alcohol Use Disorder With and Without Comorbid Mood Disorder
    Gunawan, Tommy
    Kim, Hannah
    Scott, Rajon
    Leiter, Noa
    McCabe, Emma
    Bergwood, Mikayla
    Luk, Jeremy
    Schwandt, Melanie
    Kwako, Laura
    Vinson, Tonette
    Horneffer, Yvonne
    George, David
    Koob, George
    Goldman, David
    Diazgranados, Nancy
    Ramchandani, Vijay
    NEUROPSYCHOPHARMACOLOGY, 2022, 47 : 502 - 503
  • [50] Full-Profile Pharmacokinetic Study of High Dose Baclofen in Subjects With Alcohol Use Disorder
    Simon, Nicolas
    Moirand, Romain
    Dematteis, Maurice
    Bordet, Regis
    Deplanque, Dominique
    Rolland, Benjamin
    FRONTIERS IN PSYCHIATRY, 2018, 9